Gunderson Dettmer represented Neuron23 on the deal.Neuron23, a biotechnology company, announced its $100 million Series C financing led by SoftBank Vision Fund 2. Neuron23 focuses on developing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
